Nintedanib and Pirfenidone Affect Growth and Differentiation of Human Alveolar Type 2 Cells
Alexey V. Bazarov(University of California, San Francisco), Paul J. Wolters(University of California, San Francisco), Ram P. Naikawadi(University of California, San Francisco), Andrea Serra-Marques(Gene Therapy Laboratory), Giulia Protti, Monica Yang(University of California, San Francisco), Jason R. Rock(Gene Therapy Laboratory), Michael Wax(University of California, San Francisco), Seoyeon Lee(University of California, San Francisco), David Garfield(Gene Therapy Laboratory), Xiaodan Cai(University of California, San Francisco), Michael Matthay(University of California, San Francisco), Jasleen Kukreja(University of California, San Francisco), Gary Green(University of California, San Francisco), Rachel Wolters(University of California, San Francisco)
Cited by 0
Related Papers
Basal cells as stem cells of the mouse trachea and human airway epithelium
|Proceedings of the National Academy of Sciences|2009|1.6k
Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition
|Proceedings of the National Academy of Sciences|2011|1.1k
Repair and Regeneration of the Respiratory System: Complexity, Plasticity, and Mechanisms of Lung Stem Cell Function
|Cell stem cell|2014|929
Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis
|Nature Communications|2020|780